Bicara Therapeutics Inc. · NASDAQ:BCAX
Raymond Debbane reported a 9.60% stake in Bicara Therapeutics Inc. (Schedule 13G/A)
Event Jun 30, 2025 · Filed Jul 31, 2025
Raymond Debbane reported a 9.60% stake in Bicara Therapeutics Inc., 5,216,969 shares, as a passive investor on Jun 30, 2025. Filed Jul 31, 2025 (Schedule 13G/A).
- Stake
- 9.60%
- Shares
- 5,216,969
- Intent
- Passive
- What changed
- Stake changed
- Filed together
- 8 holders
The filing in full
| Holder | Stake | Shares |
|---|---|---|
| Invus Public Equities, L.P. | 8.90% | 4,861,944 |
| Invus Public Equities Advisors, LLC | 8.90% | 4,861,944 |
| Invus Global Management, LLC | 8.90% | 4,861,944 |
| Siren, L.L.C. | 8.90% | 4,861,944 |
| Avicenna Life Sci Master Fund LP | 0.70% | 355,025 |
| Avicenna Life Sci Master GP LLC | 0.70% | 355,025 |
| Ulys, L.L.C. | 0.70% | 355,025 |
| Raymond Debbane | 9.60% | 5,216,969 |
Source
Related
- Bicara Therapeutics Inc.
- Invus Public Equities, L.P.
- Bicara Therapeutics Inc. shareholders
- Schedule 13G/A · T. Rowe Price Investment Management, Inc. · Oct 7, 2026
- Form 4 · Cohlhepp Ryan · Sep 10, 2026
- Schedule 13G/A · Janus Henderson Group PLC · Aug 13, 2026
- Form 4 · Hyep Ivan · Aug 12, 2026
- Form 4 · Mazumdar Claire · Aug 12, 2026